Moreover, doxycycline treatment of ABC-DLBCL cells resulted in a reduction in IKK phosphorylation and nuclear levels of the NF-κB subunits p65 and c-Rel (Figure 1E and 1F), characteristics of inhibition of NF-κB signaling [28, 29]. The gene discussed is REL; the disease is diffuse large B-cell lymphoma.